Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
About
About the Journal
Privacy Statement
Open access policy
Contact
Current
Archives
Editorial Board
Procedure for consideration and publication of materials
Guides for authors
Cost of publication
Archive 2018-2006
Search
Login
Home
/
Archives
/
Vol. 44 No. 3 (2022): Experimental Oncology
Vol. 44 No. 3 (2022): Experimental Oncology
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3
Published:
26.05.2023
Reviews
OVERVIEW OF DISCUSSIONS AND DECISION-MAKING ON TOTAL NEOADJUVANT THERAPY OF DISTAL RECTAL CANCER
P. Gordiichuk, M. Gordiichuk
178-185
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18497
ROLE OF RADIOPROTECTORS IN MINIMIZATION OF STOCHASTIC EFFECTS OF RADIATION INCIDENTS
E.A. Domina, O.L. Kopylenko
186-189
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18530
Original contributions
EFFICACY OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT BURKITT/BURKITT-LIKE LYMPHOMA: A SYSTEMATIC REVIEW
U. Joshi, R. Subedi, G. Nepal, S. Gyawali, V. Agrawal, B.S. Poudyal, V.R. Bhatt, Ch.R. D’Angelo
190-197
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18599
PROFILE OF CD150 EXPRESSION IN BONE MARROW CELLS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA
L. Shlapatska, I. Gordiienko, A. Polishchuk, D. Gluzman
198-207
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18307
EXPRESSION OF IMMUNOGLOBULIN SEQUENCES HOMOLOGOUS TO ANTI-SARS-CoV-2 ANTIBODIES AND HIV IN CHRONIC LYMPHOCYTIC LEUKEMIA CASES
I. Abramenko, N. Bilous, A. Chumak, Z. Martina, I. Dyagil, D. Bazyka
208-212
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18414
ANTIPROLIFERATIVE ACTIVITIES Of EXTRACTS FROM MYCELIAL BIOMASS OF SOME MEDICINAL BASIDIOMYCETES IN HUMAN COLON CANCER CELLS COLO 205
L.V. Garmanchuk, N.P. Vedenicheva, G.A. Al-Maali, D.I. Ostapchenko, Yu.V. Tseyslyer, V.A. Liashenko, N.A. Bisko, I.V. Kosakivska, L.I. Ostapchenko
213-216
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18434
EFFECTS OF DEXTRAN-GRAFT-POLYACRYLAMIDE/ZnO NANOPARTICLES ON PROSTATE CANCER CELL LINES IN VITRO
P.A. Virych, T.V. Zadvornyi, T.V. Borikun, O.O. Lykhova, V.A. Chumachenko, P.A. Virych, V.A. Pavlenko, N.V. Kutsevol, N.Yu. Lukianova
217-221
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18452
PROGNOSTIC ROLE OF RESIDUAL TUMOR FEATURES IN HER2-NEGATIVE BREAST CANCER
L.A. Sivak, S.A. Lyalkin, N.O. Verevkina, A.F. Shipko
222-226
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18377
FEATURES OF OXIDATIVE METABOLISM AND GENETIC DISORDERS IN PERIPHERAL BLOOD LYMPHOCYTES OF PATIENTS WITH PRIMARY CERVICAL CANCER
V.M. Mikhailenko, E.A. Domina, V.S. Ivankova, L.I. Makovetska, O.A. Glavin, T.V. Khrulenko
227-233
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18486
VALIDATION OF A PANEL OF BIOMARKERS ASSOCIATED WITH AGGRESSIVE PHENOTYPE OF ENDOMETRIOID CARCINOMA OF ENDOMETRIUM
L.G. Buchynska, N.P. Iurchenko, I.P. Nesina, N.M. Glushchenko
234-238
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18513
OVARIAN TOXICITY OF FAC CHEMOTHERAPY IN RATS AND POSSIBILITY OF ITS CORRECTION WITH PLATELET-RICH PLASMA
V.A. Shamrai, O.I. Misiurko, D.I. Grebeniuk, I.V. Taran
239-242
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18393
A CYTOLOGICAL AND HISTOPATHOLOGICAL CORRELATIVE STUDY ON NEOPLASTIC LESIONS WITH MILAN SYSTEM FOR REPORTING SALIVARY GLAND CYTOPATHOLOGY
B. Sridevi, R. Veena, G. Shivashekar, Devi Bhuvanamha, M. Aswin Manikandan, P. Vineetha, S. Dinesh
243-248
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18577
EXPRESSION OF ALPHA-SMOOTH MUSCLE ACTIN IN ODONTOGENIC CYSTS AND TUMORS
Malik Ajaz Ahmad, Anish Ashok Gupta, Shubhangi Ashok Mhaske, Swati Saawarn, Sahana Ashok, Dakshata Mandora, Megha Jain
249-253
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18676
Case report
TREATMENT OPTION TO THE FERTILITY-SPARING RADICAL TRACHELECTOMY AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH CERVICAL CANCER WITH TUMOR SIZE >2CM
A. Shipko, O. Renkas, V. Svintsitskyi, V. Pryimak, O. Movchan
254-258
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18350
SYNCHRONOUS HAIRY CELL LEUKEMIA AND HEPATOCELLULAR CARCINOMA: A CASE REPORT
I.I. Starchenko, B.M. Filenko, N.V. Royko, I.V. Kornilova, N.I. Vynnyk
259-262
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18302
Letter to editor
MICRORNA-31 AS A POTENTIAL THERAPEUTIC BIOMARKER FOR ORAL SQUAMOUS CELL CARCINOMA: CURRENT EVIDENCE AND FUTURE PROSPECTS
M. Krishnan, S. Babu, S. Jayaraman, P. Daniel, A. Solomon, M. Chinnaiyan
263-264
PDF
DOI:
https://doi.org/10.32471/exp-oncology.2312-8852.vol-44-no-3.18569
Language
Українська
English
Current Issue